Seoul Virus Associated with Pet Rats, Scotland, UK, 2019
James G. Shepherd, Andrew E. Blunsum, Stephen Carmichael, Katherine Smollett, Hector Maxwell-Scott, Eoghan C.W. Farmer, Jane Osborne, Alasdair MacLean, Shirin Ashraf, Rajiv Shah, Rory Gunson, Ana da Silva Filipe, Emma J. Aarons, and Emma C. Thomson
Author affiliations: MRC–University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK (J.G. Shepherd, S. Carmichael, K. Smollett, S. Ashraf, R. Shah, A. da Silva Filipe, E.C. Thomson); National Health Service Greater Glasgow and Clyde, Glasgow (A.E. Blunsum, E.C.W. Farmer); Public Health England, London, UK (H. Maxwell-Scott, J. Osborne, E.J. Aarons); West of Scotland Specialist Virology Centre, Glasgow (A. MacLean, R. Gunson); London School of Hygiene and Tropical Medicine, London (E.C. Thomson)
Main Article
Table 1
Hematologic and biochemical markers in patient with Seoul virus infection, Scotland, UK, 2019*
Parameter (reference range) |
Day 1 |
Day 2 |
Day 4 |
Day 6 |
Day 8 |
Day 12 |
Day 29 |
Hemoglobin (115–165 × 109/L) |
136 |
144 |
114 |
133 |
112 |
122 |
128 |
Platelets (150–410 × 109/L) |
70 |
38 |
46 |
111 |
180 |
244 |
257 |
Neutrophils (2.0–7.0 × 109 cells/L) |
2.3 |
2.4 |
2.1 |
3.6 |
3.2 |
3.2 |
3.5 |
Lymphocytes (1.1–5.0 × 109 cells/L) |
0.7 |
1.2 |
1.4 |
4 |
2.4 |
2.5 |
3 |
Sodium (133–146 mmol/L) |
131 |
133 |
143 |
144 |
145 |
142 |
141 |
Urea (2.5–7.8 mmol/L) |
6.4 |
6.4 |
7.4 |
9.1 |
9.6 |
7.4 |
5.2 |
Creatinine (40–130 mmol/L) |
87 |
92 |
158 |
182 |
134 |
97 |
83 |
Estimated glomerular filtration rate (>60 mL/min) |
>60 |
56 |
30 |
25 |
36 |
53 |
>60 |
Alanine aminotransferase (<50 U/L) |
NA |
282 |
101 |
108 |
71 |
70 |
17 |
Aspartate aminotransferase (<40 U/L) |
NA |
341 |
73 |
84 |
41 |
35 |
18 |
Albumin (35–50 g/L) |
NA |
35 |
24 |
27 |
26 |
32 |
38 |
C-reactive protein (1–10 mg/L) |
58 |
104 |
50 |
30 |
14 |
3 |
NA |
Main Article
Page created: July 20, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.